Using this as an example, is a sharp increase in available for sale securities a negative indicator? This particular example is found on a small-cap company's most recent 10-Q.
I've come to believe that unless a company has a clear cut reason for doubling their corporate debt securities (i.e. product launch) then this just represents degrading fiscal health. Is this a safe assumption? Apologies if this is a no-brainer.
Submitted November 15, 2020 at 12:22AM by Stimulant_Fiend https://ift.tt/3lKon3e
